Literature DB >> 8537975

Can mammographic densities predict effects of tamoxifen on the breast?

G Ursin, M C Pike, D V Spicer, S A Porrath, R W Reitherman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8537975     DOI： 10.1093/jnci/88.2.128-a

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density.

Authors:  Anna H Wu; Darcy Spicer; Agustin Garcia; Chiu-Chen Tseng; Linda Hovanessian-Larsen; Pulin Sheth; Sue Ellen Martin; Debra Hawes; Christy Russell; Heather MacDonald; Debu Tripathy; Min-Ying Su; Giske Ursin; Malcolm C Pike
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

2.  Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.

Authors:  Sarah J Nyante; Mark E Sherman; Ruth M Pfeiffer; Amy Berrington de Gonzalez; Louise A Brinton; Erin J Aiello Bowles; Robert N Hoover; Andrew Glass; Gretchen L Gierach
Journal:  J Natl Cancer Inst       Date:  2015-02-06       Impact factor: 13.506

Review 3.  Suitable trial designs and cohorts for preventive breast cancer agents.

Authors:  Kathrin Strasser-Weippl; Paul E Goss
Journal:  Nat Rev Clin Oncol       Date:  2013-10-08       Impact factor: 66.675

Review 4.  Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.

Authors:  Emma C Atakpa; Mangesh A Thorat; Jack Cuzick; Adam R Brentnall
Journal:  Cochrane Database Syst Rev       Date:  2021-10-26

5.  Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.

Authors:  Jingmei Li; Keith Humphreys; Louise Eriksson; Gustaf Edgren; Kamila Czene; Per Hall
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

6.  Longitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using Tamoxifen.

Authors:  Sarah J Nyante; Mark E Sherman; Ruth M Pfeiffer; Amy Berrington de Gonzalez; Louise A Brinton; Erin J Aiello Bowles; Robert N Hoover; Andrew Glass; Gretchen L Gierach
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-06       Impact factor: 4.254

7.  Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer.

Authors:  Inger T Gram; Yngve Bremnes; Giske Ursin; Gertraud Maskarinec; Nils Bjurstam; Eiliv Lund
Journal:  Breast Cancer Res       Date:  2005-08-25       Impact factor: 6.466

8.  Agreement of mammographic measures of volumetric breast density to MRI.

Authors:  Jeff Wang; Ania Azziz; Bo Fan; Serghei Malkov; Catherine Klifa; David Newitt; Silaja Yitta; Nola Hylton; Karla Kerlikowske; John A Shepherd
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

Review 9.  Effect of preventive hormonal therapy on breast density: a systematic qualitative review.

Authors:  Virginie Lienart; Birgit Carly; Xin Kang; Laura Guzy; Anna-Maria Sajovitz; Fabienne Liebens
Journal:  ScientificWorldJournal       Date:  2014-04-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.